Stephens Inc Pulmonx Corp Transaction History

Stephens Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Mar 07, 2022	SELL	$29.72 - $45.1 $5.38 Million - $8.17 Million	-181,160 Reduced 39.8%	274,039 $8.79 Million
Q3 2021 Oct 27, 2021	SELL	$35.98 - $44.48 $899,499 - $1.11 Million	-25,000 Reduced 5.21%	455,199 $16.4 Million
Q2 2021 Aug 12, 2021	SELL	$37.61 - $48.0 $4.63 Million - $5.9 Million	-122,983 Reduced 20.39%	480,199 $21.2 Million
Q1 2021 May 14, 2021	BUY	$44.0 - $67.54 $26.5 Million - $40.7 Million	603,182 New	603,182 $27.6 Million

124

30.8M

1.2K

1.2K

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $236M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

Stay updated on Stephens Inc with notifications on news.